Akira Nohara

This inventor holds 21 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Nohara. Retrieved from https://idiyas.com/inventor/akira-nohara-smk97eln

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 314(Granted Patents)

Location History:

Kyoto, JA (1976 - 1978)
Kyoto, JP (1979 - 1988)

Company Filing History:

21 out of 1,858

Takeda Chemical Industries, Inc.

patents

Years Active: 1976-1988

Loading Chart...

Areas of Expertise:

Sulfenamide Derivatives

Pyridine Derivatives

Chromone Compounds

Anti-Ulcer Agents

Azaxanthone Derivatives

Benzoyl Propionic Acid

Tetrazolyl Compounds

Benzimidazole Derivatives

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4769456 - Sulfenamide derivatives and their production (1988-09-06),

2. 4738975 - Pyridine derivatives, and use as anti-ulcer agents (1988-04-19),

3. 4727150 - Pyridyl methylsulfinyl benzimidazole derivatives (1988-02-23),

4. 4716167 - 2-amino-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid (1987-12-29),

5. 4714774 - Benzoic acid derivatives and their production (1987-12-22),

6. 4689333 - 2-(2-pyridylmethylthio (sulfinyl)) benzimidazoles (1987-08-25),

7. 4672073 - Diphenoxypropane derivatives, its production and use 5-tetrazolyl (1987-06-09),

8. 4628098 - 2-[2-pyridylmethylthio-(sulfinyl)]benzimidazoles (1986-12-09),

9. 4567201 - Diphenoxypropane derivatives and compositions of antiasthmatic and (1986-01-28),

10. 4539326 - 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and (1985-09-03),

11. 4302463 - 1-Azaxanthone-3-carboxylic acids and their production (1981-11-24),

12. 4299963 - 1-Azaxanthone derivatives (1981-11-10),

13. 4267332 - 3-(Tetrazol-5-yl)-1-azaxanthones (1981-05-12),

14. 4255576 - 1-Azaxanthone derivatives (1981-03-10),

15. 4151180 - Chromone derivatives (1979-04-24),

Title: Akira Nohara: Innovator in Pharmaceutical Patents from Kyoto

Introduction: Akira Nohara is a distinguished inventor based in Kyoto, Japan, known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of 21 patents, he has made substantial advancements in the development of compounds with therapeutic applications.

Latest Patents: Among his latest inventions, Akira Nohara has developed sulfenamide derivatives that possess strong antisecretory activity and gastric mucosal protective properties. The production of these compounds involves a complex reaction of specific pyridine derivatives, which can lead to effective treatments for gastric ailments. Additionally, he has patented several pyridine derivatives that can be utilized as anti-ulcer agents, offering promising solutions for conditions such as gastric and duodenal ulcers, as well as gastritis.

Career Highlights: Akira Nohara currently works at Takeda Chemical Industries, Inc., a leading pharmaceutical company. His extensive research and innovation in the field have positioned him as a prominent figure in pharmaceutical sciences, especially in the arena of ulcer therapy. His expertise has not only contributed to advancements in treatment options but has also been recognized through various accolades within the industry.

Collaborations: Throughout his career, Nohara has collaborated with several talented individuals, including Yoshitaka Maki and Hirosada Sugihara. Their teamwork continues to foster innovation and enhance the research outputs at Takeda Chemical Industries, Inc.

Conclusion: Akira Nohara has established himself as a key innovator in the pharmaceutical landscape with his patent portfolio and collaborative efforts. His contributions to the development of new compounds for the treatment of ulcers exemplify the critical role of innovation in medicine, promoting better health outcomes for patients.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]